AUTEK(SZ:300595) Xin Lang Zheng Quan·2025-12-03 01:25Core Insights - The stock of Oupeng Vision experienced a decline of 1.82% on December 2, with a trading volume of 91.74 million yuan [1] - As of November 28, the number of shareholders for Oupeng Vision was 61,900, a decrease of 0.56% from the previous period [2] Financing and Margin Trading - On December 2, Oupeng Vision had a financing buy amount of 11.18 million yuan and a financing repayment of 10.30 million yuan, resulting in a net financing buy of 0.88 million yuan [1] - The total margin trading balance for Oupeng Vision reached 599 million yuan, with the financing balance accounting for 4.26% of the circulating market value, indicating a high level compared to the past year [1] Business Performance - For the period from January to September 2025, Oupeng Vision reported a revenue of 1.433 billion yuan, reflecting a year-on-year growth of 0.13%, while the net profit attributable to shareholders decreased by 15.41% to 442 million yuan [2] - The company has cumulatively distributed dividends of 949 million yuan since its A-share listing, with 576 million yuan distributed over the past three years [3] Shareholder Structure - As of September 30, 2025, the top ten circulating shareholders of Oupeng Vision included several ETFs, with notable reductions in holdings from major shareholders such as Huabao Zhongzheng Medical ETF and Yifangda Growth Enterprise Board ETF [3]